Simone, oncology polymath and leader

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Joe Simone was oncology’s polymath. Skilled and adept in patient care, scientific and clinical discovery, administrative leadership, education as well as mentoring to a generation of oncologists through his writings.

00003893-005
Simone with a patient at St. Jude Children’s Research Hospital in 1970. Photo courtesy of St. Jude Children’s Research Hospital.

Over the years we worked together on many shared endeavors including the National Comprehensive Cancer Network, the Huntsman Cancer Institute, and many cancer policymaking organizations. He was forever creative, insightful and astute.

But Joe’s genuine affection and respect for his colleagues and friends spilled over into everything he did.

Joe and I ran for president of ASCO in the same year. With the organization heavily weighted toward medical oncologists rather than pediatricians, that more than anything else enabled me to win.

Shortly after the election I received a handwritten letter from Joe. It said, in essence, that although he had hoped he would win, he was very pleased to see me in that role and hoped that we would have many opportunities to work together in the future.

Thirty years later, I still have that letter. Joe made a lasting impact on oncology and as well as on so many of his colleagues.

He will remain forever in the lives of so many of us.


The author is the former president, chief executive officer, and chancellor,

Fox Chase Cancer Center


Joseph V. Simone’s book, “Simone’s Maxims,” is available for download through the Cancer History Project.

Robert C. Young, MD
Former president, chief executive officer, and chancellor, Fox Chase Cancer Center
Table of Contents

YOU MAY BE INTERESTED IN

The nagging pain in Mia Sandino’s right knee set in in September 2018, and throughout her freshman year at the University of Washington, she tried to ignore it. “I was being a very naive and invincible-feeling 19-year-old,” Sandino told The Cancer Letter. “I didn’t put two and two together that this area of the knee that...

Rick Pazdur, MD, the newly appointed director for the Center for Drug Evaluation and Research at the FDA, has been described as “greyhound thin” as a result of his dedication to cycling and lifting weights in the gym each day and, for a long time, a vegetarian diet. I first met him when he was the director of the Office of Oncology Drug Products (ODP) within CDER, in 2009.
Robert C. Young, MD
Former president, chief executive officer, and chancellor, Fox Chase Cancer Center

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login